ALLO-501

· Allogene Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALLO-501, covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma [Phase 1]

See pricing